MARKER THERAPEUTICS, INC - 53 Year Dividend History | MRKR
Historical dividend payout and yield for MARKER THERAPEUTICS, INC (MRKR) since 1971. The current TTM dividend payout for MARKER THERAPEUTICS, INC (MRKR) as of November 20, 2024 is $0.00. The current dividend yield for MARKER THERAPEUTICS, INC as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.028B |
$0.003B |
|
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of innovative peptide and nucleic acid-based immunotherapeutic vaccines for the treatment and eradication of cancer, including metastatic cancer. The company's product pipeline consists of MultiTAA T Cell Therapy, TPIV200 and TPIV100/110 which are in clinical stage. Marker Therapeutics Inc., formerly known as TapImmune Inc., is based in FL, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
